Financials C.E.Management Integrated Laboratory Co.Ltd

Equities

6171

JP3639200009

Construction & Engineering

Market Closed - Japan Exchange 02:00:00 2024-07-12 am EDT 5-day change 1st Jan Change
322 JPY +0.31% Intraday chart for C.E.Management Integrated Laboratory Co.Ltd +0.31% -0.31%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 6,987 6,525 4,797 4,650 4,377 4,588
Enterprise Value (EV) 1 6,088 5,528 3,807 3,879 3,729 3,289
P/E ratio 21 x 21.4 x 16.3 x 22 x 12.5 x 24.2 x
Yield 1.55% 1.88% 2.74% 2.91% 3.57% 3.72%
Capitalization / Revenue 1.23 x 1.08 x 0.77 x 0.63 x 0.63 x 0.63 x
EV / Revenue 1.08 x 0.91 x 0.61 x 0.53 x 0.53 x 0.45 x
EV / EBITDA 8.6 x 7.4 x 5.62 x 4.63 x 4.17 x 3.95 x
EV / FCF - 15,007,133 x 17,604,545 x 13,992,530 x 15,043,197 x 3,627,297 x
FCF Yield - 0% 0% 0% 0% 0%
Price to Book 1.74 x 1.55 x 1.09 x 1.07 x 0.96 x 0.99 x
Nbr of stocks (in thousands) 14,436 14,436 14,580 14,221 14,210 14,204
Reference price 2 484.0 452.0 329.0 327.0 308.0 323.0
Announcement Date 3/28/19 3/23/20 3/23/21 3/23/22 3/23/23 3/22/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 5,663 6,066 6,207 7,341 6,998 7,326
EBITDA 1 708 747 678 838 895 833
EBIT 1 494 487 387 486 534 474
Operating Margin 8.72% 8.03% 6.23% 6.62% 7.63% 6.47%
Earnings before Tax (EBT) 1 496 459 476 444 555 374
Net income 1 326 305 293 213 349 190
Net margin 5.76% 5.03% 4.72% 2.9% 4.99% 2.59%
EPS 2 23.08 21.13 20.16 14.86 24.56 13.37
Free Cash Flow - 368.4 216.2 277.2 247.9 906.8
FCF margin - 6.07% 3.48% 3.78% 3.54% 12.38%
FCF Conversion (EBITDA) - 49.31% 31.9% 33.08% 27.7% 108.85%
FCF Conversion (Net income) - 120.78% 73.81% 130.16% 71.02% 477.24%
Dividend per Share 2 7.500 8.500 9.000 9.500 11.00 12.00
Announcement Date 3/28/19 3/23/20 3/23/21 3/23/22 3/23/23 3/22/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2022 Q1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1
Net sales 1 3,165 3,402 1,742 3,292 1,616 1,890 3,689 1,632 1,862
EBITDA - - - - - - - - -
EBIT 1 212 193 148 242 1 172 263 -21 163
Operating Margin 6.7% 5.67% 8.5% 7.35% 0.06% 9.1% 7.13% -1.29% 8.75%
Earnings before Tax (EBT) 1 290 285 149 251 7 173 271 -19 163
Net income 1 180 169 88 143 -23 101 152 -27 95
Net margin 5.69% 4.97% 5.05% 4.34% -1.42% 5.34% 4.12% -1.65% 5.1%
EPS 2 12.48 11.76 6.240 10.12 -1.670 7.170 10.76 -1.900 6.750
Dividend per Share 4.500 4.500 - 5.500 - - 6.000 - -
Announcement Date 8/13/20 8/10/21 5/12/22 8/10/22 11/10/22 5/11/23 8/9/23 11/9/23 5/9/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 899 997 990 771 648 1,299
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - 368 216 277 248 907
ROE (net income / shareholders' equity) - 7.42% 6.8% 4.86% 7.82% 4.13%
ROA (Net income/ Total Assets) - 5.65% 4.15% 4.67% 4.8% 4.28%
Assets 1 - 5,401 7,061 4,559 7,274 4,444
Book Value Per Share 2 278.0 292.0 302.0 307.0 322.0 326.0
Cash Flow per Share 2 71.90 81.00 93.30 127.0 123.0 151.0
Capex 1 651 244 199 390 43 52
Capex / Sales 11.5% 4.02% 3.21% 5.31% 0.61% 0.71%
Announcement Date 3/28/19 3/23/20 3/23/21 3/23/22 3/23/23 3/22/24
1JPY in Million2JPY
Estimates
  1. Stock Market
  2. Equities
  3. 6171 Stock
  4. Financials C.E.Management Integrated Laboratory Co.Ltd